- Home
- VTYX vs AVD Comparison
VTYX vs AVD Comparison
Compare VTYX & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- AVD
- Stock Information
- Founded
- VTYX 2018
- AVD 1969
- Country
- VTYX United States
- AVD United States
- Employees
- VTYX N/A
- AVD N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- AVD Agricultural Chemicals
- Sector
- VTYX Health Care
- AVD Industrials
- Exchange
- VTYX Nasdaq
- AVD Nasdaq
- Market Cap
- VTYX 154.9M
- AVD 158.9M
- IPO Year
- VTYX 2021
- AVD N/A
- Fundamental
- Price
- VTYX $2.30
- AVD $5.61
- Analyst Decision
- VTYX Buy
- AVD Strong Buy
- Analyst Count
- VTYX 2
- AVD 1
- Target Price
- VTYX $9.00
- AVD $12.00
- AVG Volume (30 Days)
- VTYX 441.6K
- AVD 165.0K
- Earning Date
- VTYX 11-06-2025
- AVD 11-10-2025
- Dividend Yield
- VTYX N/A
- AVD N/A
- EPS Growth
- VTYX N/A
- AVD N/A
- EPS
- VTYX N/A
- AVD N/A
- Revenue
- VTYX N/A
- AVD $529,067,000.00
- Revenue This Year
- VTYX N/A
- AVD N/A
- Revenue Next Year
- VTYX N/A
- AVD $3.54
- P/E Ratio
- VTYX N/A
- AVD N/A
- Revenue Growth
- VTYX N/A
- AVD N/A
- 52 Week Low
- VTYX $0.78
- AVD $3.28
- 52 Week High
- VTYX $3.39
- AVD $6.68
- Technical
- Relative Strength Index (RSI)
- VTYX 39.52
- AVD 62.42
- Support Level
- VTYX $2.31
- AVD $5.24
- Resistance Level
- VTYX $2.54
- AVD $5.84
- Average True Range (ATR)
- VTYX 0.14
- AVD 0.25
- MACD
- VTYX -0.02
- AVD -0.03
- Stochastic Oscillator
- VTYX 0.00
- AVD 70.13
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.